Elevated plasma levels of IL-1 had been reported in patients with AD (almost 40-fold higher than in the healthy brain)[32] and there is evidence of a correlation between IL-1β gene polymorphism and the risk of contracting the disease [33,34]. The gene discussed is IL1B; the disease is Alzheimer disease.